<DOC>
	<DOCNO>NCT02442739</DOCNO>
	<brief_summary>The primary purpose study see safe give patient head neck cancer low dose FDA approve anesthetic drug ketamine time receive radiation , chemotherapy , and/or surgery cancer treatment prevent depression effect . Researchers would also like see give ketamine time cancer treatment practical reasonably acceptable patient . New onset depression highly frequent head neck cancer , depression many negative consequence outcomes patient . Therefore , investigator would also like see give patient ketamine routine cancer treatment prevent onset depression negative effect cancer treatment outcome , also help anxiety , pain , quality life . The study also use placebo compare good and/or bad effect ketamine . A placebo active drug look ketamine , liquid take mouth . Ketamine approve U.S. Food Drug Administration ( FDA ) general anesthetic diagnostic surgical procedure combine general anesthetic agent . It also show reduce cancer pain . Ketamine consider experimental study approve FDA prevention depression .</brief_summary>
	<brief_title>Study Oral Ketamine Preventing Depression Patients Undergoing Treatment Head Neck Cancer</brief_title>
	<detailed_description>This prospective , single center , double blind , randomize , two-arm feasibility study oral ketamine versus placebo prevention depression non-depressed patient head neck cancer undergo curative intent cancer therapy . Approximately 40 patient head neck cancer undergo cancer therapy randomize 1:1 receive study treatment one follow regimen : - Arm A : weekly oral administration 0.5 mg/kg ketamine - Arm B : weekly oral administration placebo Consenting patient undergo screening procedure , eligible , baseline interview brief questionnaires regard depression , mental emotional health , quality life assessment . Study treatment administer 12 week unless patient experience unacceptable toxicity , exhibit moderate severe depressive symptom , withdraws consent . Patients placebo treatment arm eligible cross ketamine arm evidence depression remove study treat standard medical management depression . Patients ask complete psychosocial measurement every two week , study medication/placebo administration , study treatment monthly five-month follow-up period .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>1 . Ability understand willingness sign write informed consent . 2 . Stage III IV epidermoid cancer head neck . 3 . Within two week start start , curative intent therapy head neck cancer . 4 . Age ≥ 18 year . 5 . Adequate liver function define : ALT &lt; 5 X institutional upper limit normal ( ULN ) AST &lt; 5 X institutional ULN Total bilirubin &lt; 5 X institutional ULN 6 . Both men woman race ethnic group eligible trial . 7 . Use antidepressant permit dose least 12 week prior study entry . 8 . Women childbearing potential men partner childbearing potential must agree use adequate contraception ( hormonal barrier method birth control ; abstinence ) prior study entry duration study participation . Should woman become pregnant suspect pregnant participating study , inform treat physician immediately . 1 . Receiving another investigational agent clinical trial prohibits participation study investigational agent . 2 . Meets Mini International Neuropsychiatric interview ( MINI ) criteria major depression , schizophrenia , bipolar illness , delirium psychosis . 3 . Has moderate severe depression accord Quick Inventory Depressive SymptomatologySelf Rated 16 ( QIDSSR16 ) score ≥ 11 . 4 . Has Suicidal Risk Assessment ( SRA ) score ≥ 6 . 5 . Use monoamine oxidase inhibitor within 14 day study entry . 6 . Diagnosed melanoma lymphoma cancer head neck . 7 . History allergic reaction hypersensitivity ketamine . 8 . Severe cardiac insufficiency ( NYHA III IV ) , uncontrolled and/or unstable cardiac coronary artery disease . 9 . History significant tachyarrhythmia , severe angina , myocardial ischemia 10 . Poorly control hypertension ( Systolic Blood Pressure &gt; 180 mmHG Diastolic Blood Pressure &gt; 1000 mmHG ) , without antihypertensive . 11 . Pregnant nursing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Ketamine</keyword>
	<keyword>Prevention depression</keyword>
</DOC>